CCBs (e.g., amlodipine and nifedipine), which primarily cause vascular dilation; and non-dihydropyridine (non-DHP) CCBs (e.g., verapamil and diltiazem), which have effects on the heart. DHP CCBs have ...

THERE has been much interest in the etiology and treatment of gingival hyperplasia occurring in patients receiving diphenylhydantoin sodium ¶ since the effectiveness of the drug as an ...

Nifedipine, amlodipine, verapamil, and diltiazem are commonly linked to gingival hyperplasia. CCBs promote gingival overgrowth by affecting calcium influx into gingival cells, which results in ...

Portnoy and colleagues described the rare adverse event of amlodipine-induced gingival overgrowth, which is characterized by an increase in the volume of connective tissue matrix in the gums. Several ...

CCBs, as a group, have been frequently implicated as an etiologic factor for a common oral condition seen among patients seeking dental care: drug-induced gingival enlargement or overgrowth.

Gingival hyperplasia is when gums grow too much around teeth because there are too many gum cells. This makes the gums get bigger and it's a common problem in gum diseases. People also call it ...

A: Let your primary care provider know about this complication (gingival hyperplasia). It is a known side effect of amlodipine and other calcium antagonists such as verapamil and nifedipine.

Drug-induced gingival hyperplasia is a type of hyperplasia from drug side effects. In general, gingival hyperplasia refers to a condition in which the gum tissues surrounding the teeth grow ...